Literature DB >> 8559370

Horner's syndrome after coronary artery bypass surgery.

D Barbut1, J P Gold, M H Heinemann, R B Hinton, R R Trifiletti.   

Abstract

We established the frequency of Horner's syndrome (HS) in 248 elective patients after coronary artery bypass surgery. Patients were evaluated neurologically pre- and post-operatively and 6 months after surgery. Nineteen patients (7.7%) developed unilateral HS postoperatively, 12 involving the left eye. The finding persisted in 10 patients (4%) at 6 months. When assessed 2 to 6 days, or 6 months, postoperatively, HS tended to be isolated and not associated with C8/T1 plexopathy. Among nondiabetic subjects, hypertensive patients had a higher frequency of HS than normotensive patients (10.6% versus 2.9%, p = 0.05). Among normotensive subjects, diabetic patients had a higher frequency than nondiabetic patients (15% versus 2.9%, p = 0.08). There was no association between HS, age, sex, internal mammary artery grafting, or length of cardiopulmonary bypass time. In summary, HS is a common and sometimes persistent complication of coronary artery bypass surgery. Hypertensive, and possibly diabetic, patients appear to be at greatest risk for developing HS.

Entities:  

Mesh:

Year:  1996        PMID: 8559370     DOI: 10.1212/wnl.46.1.181

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

Review 1.  Brachial plexus injury as an unusual complication of coronary artery bypass graft surgery.

Authors:  A Y Chong; C E Clarke; W R Dimitri; G Y H Lip
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

Review 2.  Horner syndrome: clinical perspectives.

Authors:  Sivashakthi Kanagalingam; Neil R Miller
Journal:  Eye Brain       Date:  2015-04-10

3.  Horner's Syndrome Incidental to Medullary Thyroid Carcinoma Excision: Case Report and Brief Literature Review.

Authors:  Nicholas S Mastronikolis; Sofia P Spiliopoulou; Vassiliki Zolota; Theodoros A Papadas
Journal:  Case Rep Otolaryngol       Date:  2016-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.